ASX Market Close: Index breaks a record before paring gains | November 28, 2024

The Market Herald
2024-11-28

The ASX200 closed up 0.45% at 8,444 points after hitting a new high in intra-day trade.

The local bourse surged to a record of 8,477 before paring gains, despite a weak lead from Wall Street ahead of the Thanksgiving Day break.

Back home, Health Care was the strongest performing sector, up 1.6%, followed by Financials, up 0.8% and Utilities, up 0.6%. Energy and Industrials were the worst performers, both down around 0.3%.

In the Green

Spartan Resources (ASX: SPR) closed up 6.42% on news recent surface drilling confirmed a significant new gold discovery, named Freak, immediately south of the Pepper Gold Deposit at its 100%-owned Dalgaranga Gold Project (DGP) in WA.

Spartan Resources closed at $1.41.

Clarity Pharmaceuticals (ASX:CU6) closed up 6.89% on news of its Phase 2 diagnostic trial, aimed at improving diagnosis and management of neuroendocrine tumours.

Clarity Pharmaceuticals closed at $6.36.

Imricor Medical Systems (ASX:IMR) closed up 2.8% after inking a licensing agreement with Swiss company ADIS for the commercialisation of its NorthStar AI modules.

Imricor Medical Systems called it a day at $1.10.

In the Red

Webjet (ASX:WJL) closed down 7.69% after the Australian Competition and Consumer Commission kicked off Federal Court proceedings against the company. The ACCC alleges the company engaged in false and misleading flight pricing and booking practices.

Webjet closed at 78 cents.

Humm Group (ASX:HUM) closed down 12.26% following an update at its AGM. The company says inflation and cost of living pressures are likely to affect FY25 results. Investors responded by marking down the stock.

Humm closed at 68 cents.

Novonix (ASX:NVX) shed a further 8.61% on the back of an institutional placement. The company raised $44.4 million at an offer price of 60 cents per new share. This represented a sizeable discount of approximately 38% to the prevailing share price.

Novonix wrapped up at 69 cents.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10